Literature DB >> 15265553

Evaluation of the clearance characteristics of various microspheres in the human nose by gamma-scintigraphy.

Mohsen Tafaghodi1, S Abolghasem Sajadi Tabassi, Mahmood-Reza Jaafari, S Rasoul Zakavi, Mahdi Momen-Nejad.   

Abstract

The nasal cavity possesses many advantages as a site for drug delivery, such as; ease of administration, applicability for long-term treatments and a large surface area for absorption. One important limiting factor for nasal drug delivery is the limited time available for absorption within the nasal cavity due to mucociliary clearance. Several drug delivery systems including different kinds of microspheres have been tried for encapsulation of drugs and increasing the residence time in nasal cavity. In this study the clearance rate of three kinds of microspheres (Alginate, PLGA, and Sephadex) was determined by gamma-scintigraphy with lactose powder being used as negative control. (99m)Tc labeled microspheres were prepared using technetium pertechnetate in the presence of a potent reducing agent, stannus chloride. The labeling procedure was set in a manner that each 3-5 mg of microspheres contained 2 MBq of radioactivity. Labeling efficiency was calculated by paper chromatography using acetone as a mobile phase. Each delivery system containing 2 MBq of activity was administered into right nostril of four healthy volunteers and 1 min static views were repeated each half an hour until 4 h. Clearance rates were compared using two regions of interest (ROIs); the initial site of deposition of particles, and all of the nasopharynx region. The clearance rate of each one of microspheres was calculated after applying the physical decay corrections. The mean labeling efficiencies for Alginate, PLGA, and Sephadex microspheres were calculated as 60%, 59%, and 74%, respectively. The cleared percent of formulations from nasopharynx region after 4 h was determined as follows: PLGA microspheres 48.5 +/- 8.2%; Alginate microspheres 45.0 +/- 0.8%; Sephadex microspheres 63.1 +/- 3.4%; lactose powder 74.5 +/- 4.9%. Alginate and PLGA microspheres showed the lowest clearance rate compared to lactose powder (P < 0.0001 and P < 0.001, respectively), followed by Sephadex microspheres (P < 0.01). The clearance profiles of formulations from deposition ROI and nasopharynx ROI were identical. This study shows that Alginate and PLGA microspheres have the highest mucoadhesion properties and are suitable nasal delivery systems. Futhermore, this study proves that limiting step for the nasal clearance of nasally administered particulate systems is their dislocation from the initial site of deposition, and their following interactions with mucus layer in the rest of the nasal passage does not significantly affect the clearance time.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15265553     DOI: 10.1016/j.ijpharm.2004.05.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Immunization against leishmaniasis by PLGA nanospheres encapsulated with autoclaved Leishmania major (ALM) and CpG-ODN.

Authors:  Mohsen Tafaghodi; Ali Khamesipour; Mahmoud R Jaafari
Journal:  Parasitol Res       Date:  2010-12-02       Impact factor: 2.289

2.  Permeation studies of indomethacin from different emulsions for nasal delivery and their possible anti-inflammatory effects.

Authors:  H Yeşim Karasulu; Z Evren Sanal; Sumru Sözer; Tamer Güneri; Gökhan Ertan
Journal:  AAPS PharmSciTech       Date:  2008-02-14       Impact factor: 3.246

3.  Formulations for Intranasal Delivery of Pharmacological Agents to Combat Brain Disease: A New Opportunity to Tackle GBM?

Authors:  Matthias van Woensel; Nathalie Wauthoz; Rémi Rosière; Karim Amighi; Véronique Mathieu; Florence Lefranc; Stefaan W van Gool; Steven de Vleeschouwer
Journal:  Cancers (Basel)       Date:  2013-08-14       Impact factor: 6.639

4.  Fungi, β-glucan, and bacteria in nasal lavage of greenhouse workers and their relation to occupational exposure.

Authors:  Anne Mette Madsen; Kira Tendal; Trine Thilsing; Margit W Frederiksen; Jesper Baelum; Jørgen V Hansen
Journal:  Ann Occup Hyg       Date:  2013-06-08

5.  Mucosal Adjuvant Potential of Quillaja saponins and Cross-linked Dextran Microspheres, Co-administered with Liposomes Encapsulated with Tetanus Toxoid.

Authors:  Faezeh Moghadam Ariaee; Mohsen Tafaghodi
Journal:  Iran J Pharm Res       Date:  2012       Impact factor: 1.696

Review 6.  Developments in the formulation and delivery of spray dried vaccines.

Authors:  Gaurav Kanojia; Rimko Ten Have; Peter C Soema; Henderik Frijlink; Jean-Pierre Amorij; Gideon Kersten
Journal:  Hum Vaccin Immunother       Date:  2017-10-03       Impact factor: 3.452

7.  The mucosal adjuvant potential of cross-linked dextran microspheres as dry powder.

Authors:  Mohsen Tafaghodi; Maryam Eskandari
Journal:  Iran J Basic Med Sci       Date:  2012-05       Impact factor: 2.699

Review 8.  Potential of polymeric particles as future vaccine delivery systems/adjuvants for parenteral and non-parenteral immunization against tuberculosis: A systematic review.

Authors:  Farzad Khademi; Mohammad Derakhshan; Arshid Yousefi-Avarvand; Mohsen Tafaghodi
Journal:  Iran J Basic Med Sci       Date:  2018-02       Impact factor: 2.699

9.  Spray Freeze Dried Lyospheres® for Nasal Administration of Insulin.

Authors:  Tuğrul Mert Serim; Jan Kožák; Annika Rautenberg; Ayşe Nurten Özdemir; Yann Pellequer; Alf Lamprecht
Journal:  Pharmaceutics       Date:  2021-06-08       Impact factor: 6.321

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.